On a cold Midwestern morning in early 2026, a new venture fund is quietly sharpening its pencil.
On January 21, 2026, Crossroads Health Ventures (CHV) announced a $21+ million early-stage fund designed to do something Indiana has been trying to do for many years: keep its best life science ideas at home long enough for them to become world-class companies.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
